Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Approved for marketing
×
INDUSTRY
×
Pathologic Processes
×
Clear all
Filters
3
NCT05592743
2024-11-05
Vorasidenib Expanded Access Program
Servier
Approved for marketing